{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-332982","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2026-08-04T20:39:02+00:00","discovered_at":"2026-08-04T20:40:01.355563+00:00","generated_at":"2026-08-04T20:40:06.341815+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LeMaitre Q2 sales $70.4M (+10%), EPS $0.74 (+23%); Artegraft up 34%; guides FY $276.3M","bullets":["Sales $70.4M, +10% YoY (+10% organic); EPS $0.74 (+23%).","Gross margin 72.1% (+210 bps); operating income $20.4M (+26%).","Artegraft sales +34%; approved in 56 countries, 21% of sales.","FY guidance: sales mid $276.3M (+11% org), EPS mid $2.89 (+15% GAAP, +21% adj).","Quarterly dividend $0.25/share payable Sept 3, 2026 to record Aug 20, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-332982","json":"https://secwatch.observer/filing/0001193125-26-332982.json","markdown":"https://secwatch.observer/filing/0001193125-26-332982.md","text":"https://secwatch.observer/filing/0001193125-26-332982.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/0001193125-26-332982-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526332982/d320964d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T20:40:06.341815+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}